Other

Pfizer Corporation

Jeffrey Thomas Kohrt

Christopher Franklin Bigge

Jeremy John Edmunds

Kevin James Filipski

Agustin Casimiro-Garcia

Danette Andrea Dudley

Chad Alan Van Huis

The present invention provides compounds of Formula (I): wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.

Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

The present invention provides compounds of Formula (I):wherein A, B, C, G, and Whave any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.

Growing community of inventors

Ann Arbor, MI, United States of America

Jeffrey Thomas Kohrt